| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Canada | 3 | |
| #3 | Australia | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ecsedy Jeffrey | 10 |
| #2 | Manfredi Mark | 10 |
| #3 | Nagahisa Atsushi | 8 |
| #4 | Okumura Takako | 8 |
| #5 | Take Yukinori | 6 |
| #6 | Castro Alfredo C | 3 |
| #7 | Okumura Yoshiyuki | 2 |
| #8 | Jonaitis David T | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA3113468A1 | Grapiprant unit dosage forms | |
| WO2020014465A1 | Polymorphic compounds and uses thereof | |
| CA3107023A1 | Ep4 inhibitors and synthesis thereof | |
| CN112292128A | EP4 inhibitors and uses thereof |